Literature DB >> 23880646

Rotavirus G9P[4] in 3 countries in Latin America, 2009-2010.

Osbourne Quaye, Sharla McDonald, Mathew D Esona, Freda C Lyde, Slavica Mijatovic-Rustempasic, Sunando Roy, Dina J Castro Banegas, Yolanda Mencos Quiñonez, Blanca L Chinchilla, Fabián Gómez Santiago, Herlinda García Lozano, Gloria Rey-Benito, Lúcia H de Oliveira, Jon R Gentsch, Michael D Bowen.   

Abstract

Entities:  

Keywords:  Guatemala; Honduras; Latin America; Mexico; NSP4; VP4; VP7; enteric infections; reassortant; rotavirus; rotavirus G9P[4]; viruses

Mesh:

Substances:

Year:  2013        PMID: 23880646      PMCID: PMC3739533          DOI: 10.3201/eid1908.130288

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Group A rotaviruses are the most common viral cause of acute gastroenteritis in young children. The most frequently detected group A rotavirus genotype combinations include G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8]. The G9 genotype has been associated with multiple P types, including P[8], P[6], and P[4], although genotype G9P[8] is predominant (). In Latin America, a large number of unusual G-P combinations have been reported, and among these is the rare G9P[4] genotype, which was identified in Brazil in the 1990s (), and later reported infrequently elsewhere in Latin America (). In 2010, cases of group A rotavirus gastroenteritis associated with genotype G9P[4] were reported in Mexico (). Increases in the incidence of group A rotavirus gastroenteritis were reported in 2010 in Mexico and Guatemala and in 2009 in Honduras (http://new.paho.org/hq/dmdocuments/2010/Epi_Alerts_2010_mar_5_rotavirus.pdf). In response to these reports of increased group A rotavirus disease, fecal samples collected in Chiapas State, Mexico (in 2010, 30% of the cases in Mexico were from Chiapas), Guatemala, and Honduras in 2009–2010 that were positive by enzyme immunoassay were sent to the US Centers for Disease Control and Prevention (Atlanta, GA, USA) for characterization. Viral protein 4 (VP4) (P) and VP7 (G) genotyping, nucleotide sequencing, and genotype identification were performed by using consensus and genotype-specific oligonucleotide primers (), and sequences were subjected to phylogenetic analyses. VP6 and nonstructural protein 4 (NSP4) genes of selected samples were also sequenced. For 26 samples from Mexico, G9 accounted for ≈90% of all the G types; all samples had mixed P types. Approximately 80% of samples were genotype G9P[4,8]; genotypes G3P[4,8], G3,9P[4,8], and G9P[4,9] accounted for the remaining samples. We hypothesize that the G9P[4,8] genotype was the result of mixed G9P[4] and G9P[8] infections by strains with homologous G9 VP7 genes. For 41 samples from Guatemala, G9P[4] accounted for 66%, followed by G9P[8] (32%), and G3,9P[4,8] (2%). For 50 samples from Honduras, 50% were G1P[8] and 36% were G9P[4]. G3P[8], G1,3P[8], and G4P[6] comprised the remaining samples. Results showed an increase in prevalence of the rare G9P[4] strain, which was the predominant strain in Guatemala and Mexico, and the second most predominant strain in Honduras, after G1P[8]. Group A rotavirus genotypes G1P[8] and G3P[8] have been reported to be predominant in Mexico (). G1P[8] and G2P[4] were associated with most group A rotavirus infections in Guatemala (,) and G2P[4] predominated in Honduras (). G9P[4] has not been reported in Guatemala or Honduras. In Mexico, the outbreak might have originated from a common source, such as untreated drinking water (http://new.paho.org/hq/dmdocuments/2010/Epi_Alerts_2010_mar_5_rotavirus.pdf). Phylogenetic analysis of G9 gene sequences from the 3 countries showed that they clustered in a sublineage and were closest to G9P[8] strains circulating globally (Figure, Appendix, panel A). VP4 genes from the 3 countries also clustered within a sublineage of a clade containing global strains (Figure, Appendix, panel B). VP6 sequences clustered within a sublineage of the I2 genotype clade (Figure, Appendix, panel C). NSP4 gene sequences clustered within a sublineage of the E6 genotype clade, which they shared with group A rotavirus strains from India and Bangladesh (Figure, Appendix, panel D).
Figure

Maximum-likelihood phylograms indicating genetic relationships of nucleotide sequences of A) viral protein 7 (VP7), B) VP4, C) VP6, and D) nonstructural protein 4 (NSP4) genes of human G9P[4] group A rotavirus (RVA) strains from Mexico, Guatemala, and Honduras, and sequences of human and animal RVA strains from GenBank. Partial VP4 (VP8* region), VP7 and VP6 gene sequences (742, 783, and 1,155 bases, respectively) and complete gene sequences of NSP4 (528 bases) were aligned with cognate reference strain sequences by using ClustalW in MEGA 5.05 (http://megasoftware.net/mega.php). The optimal evolutionary model that best fit each sequence dataset was identified by using MEGA 5.05. Maximum-likelihood trees were constructed by using SEAVIEW version 4 (www.seaviewfishing.com/DownloadSoftware.html), and approximate likelihood ratio test (aLRT) statistics were computed for estimation of branch support. On the basis of Akaike information criteria with a correction for finite sample sizes, we selected the Tamura-Nei plus gamma, general time reversible plus gamma, general time reversible plus invariant sites, and Hasegawa-Kishino-Yano plus gamma models for genes VP4, VP7, VP6, and NSP4, respectively. Trees are drawn to scale. Only aLRT values ≥70% are shown. Solid circles indicate G9P[4] strains from Mexico, squares indicate G9P[4] strains from Guatemala, and solid inverted triangles indicate G9P[4] strains from Honduras sequenced in this study. Scale bars indicate genetic distances. MEX, Mexico; GTM, Guatemala; HND, Honduras; MUS, Mauritius; GHA, Ghana; ZAF, South Africa; IND, India; THA, Thailand; BRA, Brazil; NGA, Nigeria; CMR, Cameroon; KEN, Kenya; CHN, China; MWI, Malawi; USA, United States; VNM, Vietnam; JPN, Japan; GBR, United Kingdom; RUS, Russia; BGD, Bangladesh; DEU, Germany; PHL, The Philippines; ITA, Italy; BEL, Belgium; ARG, Argentina.

Maximum-likelihood phylograms indicating genetic relationships of nucleotide sequences of A) viral protein 7 (VP7), B) VP4, C) VP6, and D) nonstructural protein 4 (NSP4) genes of human G9P[4] group A rotavirus (RVA) strains from Mexico, Guatemala, and Honduras, and sequences of human and animal RVA strains from GenBank. Partial VP4 (VP8* region), VP7 and VP6 gene sequences (742, 783, and 1,155 bases, respectively) and complete gene sequences of NSP4 (528 bases) were aligned with cognate reference strain sequences by using ClustalW in MEGA 5.05 (http://megasoftware.net/mega.php). The optimal evolutionary model that best fit each sequence dataset was identified by using MEGA 5.05. Maximum-likelihood trees were constructed by using SEAVIEW version 4 (www.seaviewfishing.com/DownloadSoftware.html), and approximate likelihood ratio test (aLRT) statistics were computed for estimation of branch support. On the basis of Akaike information criteria with a correction for finite sample sizes, we selected the Tamura-Nei plus gamma, general time reversible plus gamma, general time reversible plus invariant sites, and Hasegawa-Kishino-Yano plus gamma models for genes VP4, VP7, VP6, and NSP4, respectively. Trees are drawn to scale. Only aLRT values ≥70% are shown. Solid circles indicate G9P[4] strains from Mexico, squares indicate G9P[4] strains from Guatemala, and solid inverted triangles indicate G9P[4] strains from Honduras sequenced in this study. Scale bars indicate genetic distances. MEX, Mexico; GTM, Guatemala; HND, Honduras; MUS, Mauritius; GHA, Ghana; ZAF, South Africa; IND, India; THA, Thailand; BRA, Brazil; NGA, Nigeria; CMR, Cameroon; KEN, Kenya; CHN, China; MWI, Malawi; USA, United States; VNM, Vietnam; JPN, Japan; GBR, United Kingdom; RUS, Russia; BGD, Bangladesh; DEU, Germany; PHL, The Philippines; ITA, Italy; BEL, Belgium; ARG, Argentina. The high degree of genetic similarity among these strains in all 4 genes (99.6%–100%), as demonstrated in this study, suggests that strains from all 3 countries had a common origin. In regions of overlapping sequence, VP4 gene sequences from this study shared 98.3%–100% identity (408 bases) with G9P[4] strains from Mexico (GenBank accession nos. JN180414–JN180451), and VP7 gene sequences shared 97.9%–98.9% identity (97 bases) (GenBank accession nos. JN180376–JN180413). Rahman et al. have hypothesized that the G9P[4] genotype combination was formed by reassortment between more frequently occurring strains (e.g., G2P[4] and G9P[6] strains) (). Potential parental strains have been circulating at high levels in Latin America for ≈30 years. During this period, G9 and P[4] accounted for 15% and 22% of all G and P types, respectively, in Latin America and the Caribbean (). Only 0.4% of strains were G9P[4] during this period, which suggests that the markedly increased prevalence of this genotype in 2009–2010 was the result of a dramatic event, such as genetic reassortment. Previous studies of G9P[4] strains examined only VP4 and VP7 genes and had not characterized VP6 and NSP4 genes of these strains. The presence of an NSP4 genotype E6 gene within these viruses was surprising. The NSP4 E6 genotype has been described in only 5 strains, all of which were from human cases of infection in Bangladesh or India (,) and were associated with VP4 genotype P[6] and VP7 genotypes G8 or G12. The complete global distribution of this NSP4 genotype remains to be determined. Although many factors account for increased reports of group A rotavirus gastroenteritis observed in Mexico, Guatemala, and Honduras in 2009–2010, our data suggest emergence of the previously rare G9P[4] group A rotavirus genotype in these countries. Whether the G9P[4] genotype becomes the common strain in Latin America or elsewhere remains to be determined.
  10 in total

1.  Rotavirus strains bearing genotype G9 or P[9] recovered from Brazilian children with diarrhea from 1997 to 1999.

Authors:  N Santos; E M Volotão; C C Soares; M C Albuquerque; F M da Silva; T R de Carvalho; C F Pereira; V Chizhikov; Y Hoshino
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs.

Authors:  Krisztián Bányai; Brigitta László; Jazmin Duque; A Duncan Steele; E Anthony S Nelson; Jon R Gentsch; Umesh D Parashar
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

3.  United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.

Authors:  Jennifer J Hull; Elizabeth N Teel; Tara K Kerin; Molly M Freeman; Mathew D Esona; Jon R Gentsch; Margaret M Cortese; Umesh D Parashar; Roger I Glass; Michael D Bowen
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

4.  Emerging G9 rotavirus strains in the northwest of China.

Authors:  Mustafizur Rahman; Xue-lei Yang; He Sun; Khandaker Mahzebin; Natasha Willemina Verstappen; Luís Novo; Jelle Matthijnssens; Marc Van Ranst
Journal:  Virus Res       Date:  2008-08-15       Impact factor: 3.303

5.  Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico.

Authors:  Catherine Yen; Jesùs Reyna Figueroa; Edgar Sánchez Uribe; Luz Del Carmen-Hernández; Jacqueline E Tate; Umesh D Parashar; Manish M Patel; Vesta Richardson López-Collado
Journal:  J Infect Dis       Date:  2011-08-02       Impact factor: 5.226

Review 6.  Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis.

Authors:  Alexandre C Linhares; Juan A Stupka; Agustín Ciapponi; Ariel E Bardach; Demián Glujovsky; Patricia K Aruj; Agustina Mazzoni; Jefferson A Buendía Rodriguez; Analía Rearte; Tatiana M Lanzieri; Eduardo Ortega-Barria; Romulo Colindres
Journal:  Rev Med Virol       Date:  2011-03-07       Impact factor: 6.989

7.  Rotavirus disease burden among children <5 years of age--Santa Rosa, Guatemala, 2007-2009.

Authors:  Jennifer Cortes; Wences Arvelo; Beatriz Lopez; Lissette Reyes; Tara Kerin; Rashi Gautam; Manish Patel; Umesh Parashar; Kim A Lindblade
Journal:  Trop Med Int Health       Date:  2011-12-19       Impact factor: 2.622

8.  Evolutionary history and global spread of the emerging g12 human rotaviruses.

Authors:  Mustafizur Rahman; Jelle Matthijnssens; Xuelei Yang; Thomas Delbeke; Ingrid Arijs; Koki Taniguchi; Miren Iturriza-Gómara; Nadia Iftekharuddin; Tasnim Azim; Marc Van Ranst
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

9.  Genomic characterization of nontypeable rotaviruses and detection of a rare G8 strain in Delhi, India.

Authors:  Sumit Sharma; Vinod K Paul; Maharaj K Bhan; Pratima Ray
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

10.  Rotavirus P[4]G2 in a vaccinated population, Brazil.

Authors:  Manish M Patel; Lucia Helena de Oliveira; Ana Maria Bispo; Jon Gentsch; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

  10 in total
  7 in total

Review 1.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

2.  Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013.

Authors:  Michael D Bowen; Slavica Mijatovic-Rustempasic; Mathew D Esona; Elizabeth N Teel; Rashi Gautam; Michele Sturgeon; Parvin H Azimi; Carol J Baker; David I Bernstein; Julie A Boom; James Chappell; Stephanie Donauer; Kathryn M Edwards; Janet A Englund; Natasha B Halasa; Christopher J Harrison; Samantha H Johnston; Eileen J Klein; Monica M McNeal; Mary E Moffatt; Marcia A Rench; Leila C Sahni; Rangaraj Selvarangan; Mary A Staat; Peter G Szilagyi; Geoffrey A Weinberg; Mary E Wikswo; Umesh D Parashar; Daniel C Payne
Journal:  J Infect Dis       Date:  2016-06-14       Impact factor: 5.226

3.  Detection of Rotavirus Genotypes in Korea 5 Years after the Introduction of Rotavirus Vaccines.

Authors:  Ju-Young Chung; Min-Sung Kim; Tae Woong Jung; Seong Joon Kim; Jin-Han Kang; Seung Beom Han; Sang Yong Kim; Jung Woo Rhim; Hwang-Min Kim; Jae Hong Park; Dae Sun Jo; Sang Hyuk Ma; Hye-Sook Jeong; Doo-Sung Cheon; Jong-Hyun Kim
Journal:  J Korean Med Sci       Date:  2015-09-12       Impact factor: 2.153

4.  Full Genome Sequence of a Reassortant Human G9P[4] Rotavirus Strain.

Authors:  Jamie Lewis; Sunando Roy; Mathew D Esona; Slavica Mijatovic-Rustempasic; Christine Hardy; Yuhuan Wang; Margaret Cortese; Michael D Bowen
Journal:  Genome Announc       Date:  2014-12-11

5.  Whole-Genome Analyses Identifies Multiple Reassortant Rotavirus Strains in Rwanda Post-Vaccine Introduction.

Authors:  Sebotsana Rasebotsa; Jeannine Uwimana; Milton T Mogotsi; Kebareng Rakau; Nonkululeko B Magagula; Mapaseka L Seheri; Jason M Mwenda; M Jeffrey Mphahlele; Saheed Sabiu; Richard Mihigo; Leon Mutesa; Martin M Nyaga
Journal:  Viruses       Date:  2021-01-12       Impact factor: 5.048

6.  Characterisation of a rare, reassortant human G10P[14] rotavirus strain detected in Honduras.

Authors:  Osbourne Quaye; Sunando Roy; Kunchala Rungsrisuriyachai; Mathew D Esona; Ziqian Xu; Ka Ian Tam; Dina J Castro Banegas; Gloria Rey-Benito; Michael D Bowen
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-01       Impact factor: 2.743

7.  Isolation and characterization of a new candidate human inactivated rotavirus vaccine strain from hospitalized children in Yunnan, China: 2010-2013.

Authors:  Jin-Yuan Wu; Yan Zhou; Guang-Ming Zhang; Guo-Fa Mu; Shan Yi; Na Yin; Yu-Ping Xie; Xiao-Chen Lin; Hong-Jun Li; Mao-Sheng Sun
Journal:  World J Clin Cases       Date:  2018-10-06       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.